Effective October 2, 2018, California physicians must consult California’s PDMP (the Controlled Substance Utilization Review and Evaluation System, or CURES) – prior to prescribing Schedule II, III or IV controlled substances. The California Medical Association recently co-hosted a live CURES webinar with the California Department of Justice and the Medical Board of California regarding this new duty-to-consult requirement.
California
White Paper, “Opioid Analgesics in California: Relieving Pain, Preventung Misuse, Finding Balance.”
California ACEP Safe Prescribing Guidelines
CDPH Resources for Opioid Prescribers (2017)
California Department of Public Health